Xinrong
Suzhou
About Xinrong
Jiangsu Xinrong Science & Technology Development Co.,Ltd was founded in 1996, combines manufacturing and trading. The factory area is more than 60,000 square meters; modern office building and workshop take up more than 40000 square meters and there are more than 200 experienced high-quality staff. With high-speed development,the annual output value grew rapidly by doubling every year since it established in 1996.The company specializes in researching,developing and manufacturing various complete sets of plastic machinery,including plastic pipe extrusion line,profile extrusion line,sheet extrusion line and plastic recycling machine.Customers accept us because of our good quality,excellent service and innovative spirit.The company was rated as Quality Trustworthy Enterprise,High-integrity Enterprise and it acquires ISO Quality Management System Certification,CE Certification,Well-known Enterprise Brand Certification and 3A Credit Rates Certification. Xinrong sticks to the road of people oriented and market-oriented,and takes quality as life,service as mission and science as pioneer.We sincerely hope to cooperate with friends at home & abroad,and create a better future together. At present, the annual output value of company is up to 20 million dollars.The main products are popular in the domestic market,such as the East China market,Southwest market,Northeast market and Central China market.The products are also exported to international market,including Russia,Australia, Southeast Asia,Middle East,East Europe.Africa and other countries.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Total funding: $100.0M
- Funding stage: Private Equity
- Last round: Private Equity (Sep 2014)
- Website: xinrong.net
- Phone: +86-13115119251
Industries & Categories
Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/xinrong-2768826 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.